September 30, 2026 — RNews

#recurrence — Wednesday, September 30, 2026 (1 items)

hot top new

← prev day next day →

1

A competitive BB-ELISA for anti-toxin B neutralising antibodies in assessing risk of recurrent Clostridioides difficile infection: a retrospective cohort study from the MODIFY I and II trials. (linkinghub.elsevier.com)

Yu H … Feng H Lancet Microbe 2026-09-30

#infection #antibody #immunoassay #immunity #recurrence